Nature and reporting characteristics of UK health technology assessment systematic reviews

Abstract Background A recent study by Page et al. (PLoS Med. 2016;13(5):e1002028) claimed that increasing numbers of reviews are being published and many are poorly-conducted and reported. The aim of the present study was to assess how well reporting standards of systematic reviews produced in a Hea...

Full description

Bibliographic Details
Main Authors: Christopher Carroll, Eva Kaltenthaler
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12874-018-0498-6
_version_ 1819144408419794944
author Christopher Carroll
Eva Kaltenthaler
author_facet Christopher Carroll
Eva Kaltenthaler
author_sort Christopher Carroll
collection DOAJ
description Abstract Background A recent study by Page et al. (PLoS Med. 2016;13(5):e1002028) claimed that increasing numbers of reviews are being published and many are poorly-conducted and reported. The aim of the present study was to assess how well reporting standards of systematic reviews produced in a Health Technology Assessment (HTA) context compare with reporting in Cochrane and other ‘non-Cochrane’ systematic reviews from the same years (2004 and 2014), as reported by Page et al. (PLoS Med. 2016;13(5):e1002028). Methods All relevant UK HTA programme systematic reviews published in 2004 and 2014 were identified. After piloting of the form, two reviewers each extracted relevant data on conduct and reporting from these reviews. These data were compared with data for Cochrane and “non-Cochrane” systematic reviews, as published by Page et al. (PLoS Med. 2016;13(5):e1002028). All data were tabulated and summarized. Results There were 30 UK HTA programme systematic reviews and 300 other systematic reviews, including Cochrane reviews (n = 45). The percentage of HTA reviews with required elements of conduct and reporting was frequently very similar to Cochrane and much higher than all other systematic reviews, e.g. availability of protocols (90, 98 and 16% respectively); the specification of study design criteria (100, 100, 79%); the reporting of outcomes (100, 100, 78%), quality assessment (100, 100, 70%); the searching of trial registries for unpublished data (70, 62, 19%); reporting of reasons for excluding studies (91, 91 and 70%) and reporting of authors’ conflicts of interests (100, 100, 87%). HTA reviews only compared less favourably with Cochrane and other reviews in assessments of publication bias. Conclusions UK HTA systematic reviews are often produced within a specific policy-making context. This context has implications for timelines, tools and resources. However, UK HTA systematic reviews still tend to present standards of conduct and reporting equivalent to “gold standard” Cochrane reviews and superior to systematic reviews more generally.
first_indexed 2024-12-22T12:41:40Z
format Article
id doaj.art-72acbfce9551494eb5d5387fbbe67eca
institution Directory Open Access Journal
issn 1471-2288
language English
last_indexed 2024-12-22T12:41:40Z
publishDate 2018-05-01
publisher BMC
record_format Article
series BMC Medical Research Methodology
spelling doaj.art-72acbfce9551494eb5d5387fbbe67eca2022-12-21T18:25:25ZengBMCBMC Medical Research Methodology1471-22882018-05-0118111210.1186/s12874-018-0498-6Nature and reporting characteristics of UK health technology assessment systematic reviewsChristopher Carroll0Eva Kaltenthaler1School of Health and Related Research (ScHARR), University of SheffieldSchool of Health and Related Research (ScHARR), University of SheffieldAbstract Background A recent study by Page et al. (PLoS Med. 2016;13(5):e1002028) claimed that increasing numbers of reviews are being published and many are poorly-conducted and reported. The aim of the present study was to assess how well reporting standards of systematic reviews produced in a Health Technology Assessment (HTA) context compare with reporting in Cochrane and other ‘non-Cochrane’ systematic reviews from the same years (2004 and 2014), as reported by Page et al. (PLoS Med. 2016;13(5):e1002028). Methods All relevant UK HTA programme systematic reviews published in 2004 and 2014 were identified. After piloting of the form, two reviewers each extracted relevant data on conduct and reporting from these reviews. These data were compared with data for Cochrane and “non-Cochrane” systematic reviews, as published by Page et al. (PLoS Med. 2016;13(5):e1002028). All data were tabulated and summarized. Results There were 30 UK HTA programme systematic reviews and 300 other systematic reviews, including Cochrane reviews (n = 45). The percentage of HTA reviews with required elements of conduct and reporting was frequently very similar to Cochrane and much higher than all other systematic reviews, e.g. availability of protocols (90, 98 and 16% respectively); the specification of study design criteria (100, 100, 79%); the reporting of outcomes (100, 100, 78%), quality assessment (100, 100, 70%); the searching of trial registries for unpublished data (70, 62, 19%); reporting of reasons for excluding studies (91, 91 and 70%) and reporting of authors’ conflicts of interests (100, 100, 87%). HTA reviews only compared less favourably with Cochrane and other reviews in assessments of publication bias. Conclusions UK HTA systematic reviews are often produced within a specific policy-making context. This context has implications for timelines, tools and resources. However, UK HTA systematic reviews still tend to present standards of conduct and reporting equivalent to “gold standard” Cochrane reviews and superior to systematic reviews more generally.http://link.springer.com/article/10.1186/s12874-018-0498-6Systematic reviewHealth technology assessmentHTACochrane collaborationReportingPRISMA
spellingShingle Christopher Carroll
Eva Kaltenthaler
Nature and reporting characteristics of UK health technology assessment systematic reviews
BMC Medical Research Methodology
Systematic review
Health technology assessment
HTA
Cochrane collaboration
Reporting
PRISMA
title Nature and reporting characteristics of UK health technology assessment systematic reviews
title_full Nature and reporting characteristics of UK health technology assessment systematic reviews
title_fullStr Nature and reporting characteristics of UK health technology assessment systematic reviews
title_full_unstemmed Nature and reporting characteristics of UK health technology assessment systematic reviews
title_short Nature and reporting characteristics of UK health technology assessment systematic reviews
title_sort nature and reporting characteristics of uk health technology assessment systematic reviews
topic Systematic review
Health technology assessment
HTA
Cochrane collaboration
Reporting
PRISMA
url http://link.springer.com/article/10.1186/s12874-018-0498-6
work_keys_str_mv AT christophercarroll natureandreportingcharacteristicsofukhealthtechnologyassessmentsystematicreviews
AT evakaltenthaler natureandreportingcharacteristicsofukhealthtechnologyassessmentsystematicreviews